Found 5 matching trials
Study Assessing the Safety, Immunogenicity and Dose Response of VLA15, A New Vaccine Candidate Against Lyme Borreliosis PHASE1 Observer-blind, partially randomized, multi-center dose escalation Phase I ...
Show More Learn More & Join Trial
Immunogenicity and Safety Study of a Vaccine Against Lyme Borreliosis, in Healthy Adults Aged 18 to 65 Years. Randomized, Controlled, Observer-blind Phase 2 Study. PHASE2 This is a randomized, observer-blind, placebo controlled, multicenter Phase...
Show More Location
Clinical Research Consulting, LLC
Learn More & Join Trial
Alternative Schedule Study For VLA15, a Vaccine Candidate Against Lyme Borreliosis PHASE2 In the Main Study Phase a total of 246 subjects were randomized 2:2:1 into ...
Show More Location
Clinical Research Consulting, LLC
Learn More & Join Trial
Phase 1/2 Lyme Vaccine Study PHASE1 Section 1:
The purpose of the study is to obtain safety and immunogenicity...
Show More Location
Medical University Vienna, Dept. of Clinical Pharmacology
Learn More & Join Trial
Phase 2 Study Of VLA15, A Vaccine Candidate Against Lyme Borreliosis, In A Healthy Pediatric And Adult Study Population PHASE2 VLA15-221 is a Phase 2 study, which will be conducted in two parts: Main St...
Show More Location
New England Research Associates
Learn More & Join Trial